Structures by: Farrukh M. A.
Total: 9
<i>N</i>-{4-[(2-Methoxyphenyl)sulfamoyl]phenyl}acetamide
C15H16N2O4S
Acta Crystallographica Section E (2011) 67, 2 o303-o304
a=15.7277(4)Å b=11.8351(3)Å c=16.5247(4)Å
α=90° β=90° γ=90°
<i>N</i>-[4-(Propylsulfamoyl)phenyl]acetamide
C11H16N2O3S
Acta Crystallographica Section E (2012) 68, 2 o290-o291
a=8.7791(6)Å b=14.1747(11)Å c=20.1577(14)Å
α=90° β=90° γ=90°
<i>N</i>-Ethyl-4-methyl-<i>N</i>-(3-methylphenyl)benzenesulfonamide
C16H19NO2S
Acta Crystallographica Section E (2011) 67, 8 o1909
a=19.7530(10)Å b=8.3350(10)Å c=20.395(2)Å
α=90° β=108.657(3)° γ=90°
<i>N</i>-Benzyl-4-methyl-<i>N</i>-(4-methylphenyl)benzenesulfonamide
C21H21NO2S
Acta Crystallographica Section E (2011) 67, 8 o2100
a=9.7089(6)Å b=11.5973(5)Å c=16.7661(9)Å
α=90° β=97.691(2)° γ=90°
<i>N</i>-Ethyl-<i>N</i>-(4-methylphenyl)benzenesulfonamide
C15H17NO2S
Acta Crystallographica Section E (2012) 68, 2 o326
a=15.6737(5)Å b=8.2831(2)Å c=22.3326(7)Å
α=90° β=90° γ=90°
<i>N</i>-{4-[(3-Methylphenyl)sulfamoyl]phenyl}acetamide
C15H16N2O3S
Acta Crystallographica Section E (2012) 68, 2 o437
a=12.4072(4)Å b=9.8528(4)Å c=24.7872(10)Å
α=90° β=90° γ=90°
2-(1,3-Dioxoisoindolin-2-yl)acetic acid--<i>N</i>'-[(<i>E</i>)-2-methoxybenzylidene]pyridine-4-carbohydrazide (1/1)
C10H7NO4,C14H13N3O2
Acta Crystallographica Section E (2012) 68, 8 o2442
a=7.0747(10)Å b=43.511(6)Å c=7.5477(9)Å
α=90° β=110.015(5)° γ=90°
4-[5-(4-Chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-1-yl]benzenesulfonamide
C16H14ClN3O2S
Acta Crystallographica Section E (2013) 69, 2 o295-o296
a=15.878(5)Å b=8.209(5)Å c=12.953(5)Å
α=90.000° β=91.016(5)° γ=90.000°
3-{[5-(4-Chlorophenyl)-3-methyl-1<i>H</i>-pyrazol-1-yl]methyl}-4-<i>m</i>-tolyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C20H18ClN5S
Acta Crystallographica Section E (2013) 69, 6 o936-o937
a=8.328(5)Å b=16.407(5)Å c=14.759(5)Å
α=90.00° β=99.509(5)° γ=90.00°